Related Experiment Video
Updated: Aug 24, 2025

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Persistent or Recurrent Angina Following Percutaneous Coronary Revascularization
Muhammad Ajmal1,2, Arka Chatterjee1, Deepak Acharya3
1Division of Cardiovascular Diseases, University of Arizona, 1625 N Campbell Avenue, Tucson, AZ, 85719, USA.
Insights
Persistent angina after percutaneous coronary intervention (PCI) can be effectively managed. New diagnostic tools and phenotype-guided therapies, including functional testing and addressing coronary vasomotor disorders, improve patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Persistent or recurrent angina post-percutaneous coronary intervention (PCI) significantly impacts patient well-being and healthcare costs.
- Evolving understanding of post-PCI angina pathophysiology necessitates updated diagnostic and therapeutic strategies.
Purpose of the Study:
- To provide a comprehensive review of the mechanisms, diagnostic approaches, and treatment options for angina following PCI.
- To highlight advancements in functional testing and phenotype-guided therapies for post-PCI angina.
Main Methods:
- Review of current literature on post-PCI angina.
- Analysis of diagnostic strategies including noninvasive and invasive techniques.
- Evaluation of therapeutic options, encompassing pharmacologic and nonpharmacologic modalities.
Main Results:
- Functional testing during PCI may lead to more accurate revascularization.
- Coronary vasomotor disorders are a common cause of angina post-PCI, even without obstructive coronary artery disease.
- Invasive coronary vasoreactivity testing facilitates phenotype-guided treatment for coronary vasomotor disorders, improving angina symptoms.
Conclusions:
- A thorough diagnostic approach combining noninvasive and invasive methods is crucial for persistent or recurrent angina after PCI.
- Individualized, phenotype-guided management strategies incorporating lifestyle, pharmacologic, and nonpharmacologic treatments are essential for optimizing patient outcomes.
- Ongoing development of nonpharmacologic treatments offers future therapeutic avenues for refractory angina.
Purpose Of Review:
Persistent or recurrent angina after percutaneous coronary intervention (PCI) has substantial patient morbidity and economic impact. As knowledge of the pathophysiology of this condition has evolved, new tools for accurate diagnosis and treatment have become available. We provide a current, comprehensive review of mechanisms of post-PCI angina, diagnostic strategies, and therapeutic options.
Recent Findings:
The routine use of functional testing during PCI may enable more accurate revascularization. Coronary vasomotor disorders commonly cause angina after PCI in the absence of obstructive epicardial CAD. Invasive coronary vasoreactivity testing can enable phenotype-guided therapy of coronary vasomotor disorders with improvement in angina. Multiple nonpharmacologic modalities to treat refractory angina are under development. A comprehensive approach to the diagnosis of persistent or recurrent angina after PCI with noninvasive and invasive techniques is required. An individualized, phenotype-guided management using lifestyle, pharmacologic, and nonpharmacologic modalities is necessary to optimize outcomes.
Related Concept Videos
Angina II: Classification
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Angina III: Clinical Manifestations and Assessment
Angina V: Nursing Management
Angina I: Introduction

